FDA CDER Small Business and Industry Assistance (SBIA) Chronicles U.S. Food and Drug Administration, Center for Drug Evaluation and Research
-
- Health & Fitness
FDA’s Center for Drug Evaluation and Research Small Business and Industry Assistance (SBIA) podcast provides industry with brief synopses of trending regulatory information.
-
Considerations for Drug Products that Contain Nanomaterials
Considerations for Drug Products that Contain Nanomaterials
-
Using Bayesian statistical approaches to advance our ability to evaluate drug products
Using Bayesian statistical approaches to advance our ability to evaluate drug products
-
Insights About the FDA/EMA Parallel Scientific Advice Program for Complex Generic/Hybrid Drug Products
Insights About the FDA/EMA Parallel Scientific Advice Program for Complex Generic/Hybrid Drug Products
-
The Role of Pharmacodynamic Biomarkers in Biosimilar Drug Development
The Role of Pharmacodynamic Biomarkers in Biosimilar Drug Development
-
FDA Regulation and Quality Considerations for Cannabis and Cannabis-Derived Compounds
FDA Regulation and Quality Considerations for Cannabis and Cannabis-Derived Compounds
-
The FDA Compounding Incidents Program: Adverse Events Associated with Compounded Drugs from Outsourcing Facilities
The FDA Compounding Incidents Program: Adverse Events Associated with Compounded Drugs from Outsourcing Facilities